Cubist Pharmaceuticals Inc. (CBST) traded in a range for the majority of Monday's session, but broke out sharply to the upside in late trade. The stock finished up by 3.97 at $53.48 on the highest volume of the year.
Cubist Pharmaceuticals surged past resistance and set a new high for the year. The jump in late trade was triggered by a ruling in favor of the company by U.S. District Court Judge Gregory M. Sleet in a Delaware court, in a patent case with Hospira Inc. (HSP).
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.